Lyophilised peptides are robust. Once water goes in, that changes. A reconstituted peptide solution is a dilute, near-neutral mix of amino acids, often held at room temperature for longer than anyone intends, and opened repeatedly by different people. From a microbiologist's point of view it is a reasonable growth medium sitting in a vial with a septum that gets punctured every few days. Contamination in these solutions rarely announces itself, but it can quietly degrade the peptide, introduce endotoxin into cell-based assays and make results hard to reproduce. This checklist sets out the basic controls, borrowing from well-established pharmaceutical microbiology principles and applying them to the research bench. Everything here is in a laboratory, in-vitro context only.
1. Why peptide solutions support microbial growth
Peptides are, in effect, a nitrogen and carbon source. Many bacteria and fungi can use short peptides and free amino acids directly, and proteolytic organisms can break longer sequences down. Buffers at physiological pH, low ionic strength and the absence of a preservative all favour survival and growth. Some common contaminants, including Pseudomonas species, are able to grow at refrigeration temperatures, so a fridge slows growth but does not guarantee sterility.
The consequences go beyond visible turbidity. Microbial proteases can cleave the peptide, shifting the effective concentration. Gram-negative contaminants shed lipopolysaccharide (endotoxin), which persists after the organisms are dead and is not removed by filtration or by autoclaving at standard cycles. For anyone running cell culture or immunological assays, that matters as much as the bacteria themselves.
2. Aseptic technique when reconstituting
The aim is to prevent organisms entering in the first place. The principles in USP <797> and Ph. Eur. 5.1.1 for sterile preparations translate well to the bench, even though research work sits outside their regulatory scope.
· Work in a clean, uncluttered space, ideally a Class II biological safety cabinet or laminar airflow unit that has been switched on and allowed to purge before use, as described in the WHO Laboratory Biosafety Manual.
· Disinfect gloved hands and work surfaces with 70% isopropyl or ethanol and allow it to dry. Alcohol needs contact time to work.
· Swab the vial septum with alcohol and let it dry before puncturing. Avoid touching it afterwards.
· Use sterile, single-use syringes, needles or pipette tips for every entry. Never re-enter a vial with a used tip.
· Add the diluent slowly down the inside wall of the vial and swirl gently rather than shaking. Vigorous agitation encourages foaming and aggregation, which complicates later filtration.
· Keep the time the vial is open or exposed as short as possible, and avoid talking or moving across the open work zone.
USP <1116> is a useful reference for understanding why the immediate environment matters: most contamination in aseptic work comes from people, and airflow and technique are the main controls.
3. Choosing a diluent: sterile water or bacteriostatic water
Two reagents are commonly used to reconstitute research peptides, and they behave differently.
Sterile water contains no preservative. It adds no extra chemistry to the solution, which makes it the safer choice for cell-based assays and sensitive analytical work. The trade-off is that once the vial is opened, nothing inhibits any organism that gets in. Solutions made with sterile water should be treated as single-use or aliquoted and frozen promptly.
Bacteriostatic water is sterile water containing 0.9% benzyl alcohol as a preservative. The preservative inhibits the growth of many organisms introduced during repeated entry, which is why it is often chosen for vials that will be entered more than once. It does not sterilise a contaminated solution, and it is less effective against some organisms than others. The principle is the one tested by USP <51> Antimicrobial Effectiveness Testing: a preservative reduces risk under defined conditions; it does not replace aseptic technique. Benzyl alcohol can also be cytotoxic at assay-relevant concentrations and may interact with some peptide sequences, so check compatibility with the downstream method before choosing it.
Whichever is used, record the diluent, its lot and its expiry with the solution.
4. Filtration with 0.22 µm membranes, and its limits
Filtering through a 0.22 µm (or 0.2 µm) membrane is the standard way to sterilise a solution that cannot be heated. Sterilising-grade filters are validated by bacterial retention testing with Brevundimonas diminuta, as described in ASTM F838 and PDA Technical Report No. 26.
Filtration has limits worth knowing:
· It removes organisms, not endotoxin. A contaminated solution filtered clean may still carry lipopolysaccharide.
· Hydrophobic or aggregation-prone sequences can bind to the membrane or clog it, reducing recovery and changing the concentration. Low protein-binding membranes such as PES or PVDF help, as does a small pre-flush where the volume allows.
· Aggregates may be retained by the filter, which removes material you intended to keep. If a solution is cloudy before filtration, investigate solubility first rather than filtering the problem away.
· Filter integrity matters. Use a fresh, sealed filter for each solution and discard any that are dropped or show resistance suggesting a breach.
5. Endotoxin considerations for cell-based assays
Many cell types, particularly immune cells, respond strongly to very low endotoxin levels. An unexpected inflammatory signal in a cell assay can come from endotoxin in a reagent rather than from the peptide being studied.
· Use endotoxin-free (pyrogen-free) water, plasticware and glassware for any solution destined for cell work.
· Remember that standard autoclaving does not destroy endotoxin; depyrogenation of glassware needs dry heat at high temperature.
· Where endotoxin is a concern, it can be measured in-house using the bacterial endotoxins methods described in USP <85> and Ph. Eur. 2.6.14, such as LAL or recombinant factor C assays.
· Include appropriate vehicle controls so any background response can be identified.
6. Container-closure, storage and in-use hold times
A sealed vial with an intact stopper is a barrier. Every puncture weakens it.
· Use vials with self-sealing septa for anything accessed more than once, and use the smallest practical needle gauge.
· Store solutions refrigerated at 2 to 8 °C for short holds, or aliquot and freeze for longer storage. Avoid repeated freeze-thaw cycles, which damage both peptide and closure.
· Set an in-use hold time and a discard date for every solution, based on the diluent, the number of entries and the stability data available for the sequence. Unpreserved solutions warrant a shorter hold than preserved ones. Where no data exist, choose a conservative limit and write it down.
· Protect from light where the sequence is photosensitive.
7. Simple in-lab checks for contamination
None of these replace a validated microbiological method, but they catch obvious problems early.
· Visual inspection before every use: look for turbidity, particles, films, colour change or unexpected precipitate against light and dark backgrounds.
· Note any change in odour or pH.
· For critical solutions, streak a small volume onto a general-purpose agar plate or inoculate a broth and incubate. Growth is a clear signal to discard the stock.
· Watch the assay itself. Drifting controls, unexplained cytotoxicity or unusual cytokine responses can point back to a contaminated reagent.
If contamination is suspected, discard the solution rather than trying to rescue it, and review how it was prepared.
8. Documentation and labelling
Good records turn a contamination event from a mystery into a fixable process failure.
· Label every vial and aliquot with peptide name, lot number, concentration, diluent, date prepared, discard date and preparer's initials.
· Keep a simple log of each entry into a multi-use vial.
· Record the filter type and lot if the solution was filtered.
· Note any deviation, such as a dropped cap or a punctured glove, at the time it happens.
Summary for the bench
· Treat every reconstituted peptide as a potential growth medium.
· Reconstitute aseptically in a clean airflow cabinet with single-use sterile consumables.
· Choose sterile or bacteriostatic water deliberately, knowing the trade-offs.
· Filter through 0.22 µm where needed, but remember it does not remove endotoxin.
· Use endotoxin-free materials for cell work.
· Set and record in-use hold times and discard dates.
· Inspect before every use, and discard when in doubt.
References
1. United States Pharmacopeia. General Chapter <797> Pharmaceutical Compounding: Sterile Preparations.
2. United States Pharmacopeia. General Chapter <1116> Microbiological Control and Monitoring of Aseptic Processing Environments.
3. United States Pharmacopeia. General Chapter <51> Antimicrobial Effectiveness Testing.
4. United States Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test.
5. European Pharmacopoeia. Chapter 5.1.1 Methods of preparation of sterile products; Chapter 2.6.14 Bacterial endotoxins.
6. ASTM F838. Standard Test Method for Determining Bacterial Retention of Membrane Filters Utilized for Liquid Filtration.
7. Parenteral Drug Association. Technical Report No. 26: Sterilizing Filtration of Liquids.
8. World Health Organization. Laboratory Biosafety Manual, 4th edition, 2020.
About the author: Form Laboratories is a Perth, WA supplier of research-use-only peptides (https://formlaboratories.com). Its materials are supplied for laboratory research use only and are not for human or animal use.
Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)
.png)

.png)